Search For "dcgi"
SEC to hold meeting on Bharat Biotech's Nasal vaccine booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Read More
Dr Dangs Lab as central lab conducted tests in all three trial phases of C
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
Read More
Covovax authorisation is a vital step in India, where additional vaccine o
Updated : 4 years, 2 months ago IST
Gaithersburg/Pune (Maryland/Maharashtra)[US/India], December 29 (ANI): Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), the world's largest vaccin
Read More
Affordable, effective COVID-19 vaccine Corbevax to be especially useful in
Updated : 4 years, 2 months ago IST
Houston [US], December 29 (ANI): Texas Children's Hospital and Baylor College of Medicine announced on Tuesday (local time) that Corbevax, a protein sub-unit COVID-19 vaccine, whose technology was created and engineered at its Center for Vaccine Development (CVD), has received Emergency Use
Read More
Biological E gets approval to conduct trials of Corbevax as booster dose
Updated : 4 years, 2 months ago IST
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Read More
Dr Reddy's laboratories gets DCGI's nod to launch Molnupiravir capsules in
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 28 (ANI): Drugs Controller General of India (DCGI) on Tuesday approved Dr Reddy's laboratories for the emergency-use authorisation) to manufacture and market the oral anti-viral drug Molnupiravir capsules 200mg for the treatment of adult patients with
Read More
DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupirav
Updated : 4 years, 2 months ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Read More
Optimus Pharma granted permission for restricted use under emergency situa
Updated : 4 years, 2 months ago IST
Hyderabad (Telangana) [India], December 28 (ANI/PNN): Hyderabad, Optimus Pharma announced launching of their front line COVID-19 medication Molnupiravir in the Indian market, as they have received permission the restricted emergency use for Covid-19 drug.
Read More
Proven record for safety, says Bharat Biotech after Covaxin gets emergency
Updated : 4 years, 2 months ago IST
New Delhi [India], December 25 (ANI): Covaxin has a proven record for safety and efficacy from all the variants of COVID-19, said Bharat Biotech after its vaccine received emergency usage approval from the Drugs Controller General of India (DCGI) for kids aged between 12-18 years.
Read More
Bharat Biotech's Covaxin gets emergency use approval from DCGI for kids ab
Updated : 4 years, 2 months ago IST
New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
Read More
Bharat Biotech seeks DCGI's approval for its intranasal COVID-19 booster d
Updated : 4 years, 2 months ago IST
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
Read More
Zydus seeks DCGI nod for 'Desidustat' oral pill to treat anaemia in kidney
Updated : 4 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 23 (ANI): Pharmaceutical company Zydus Cadila on Tuesday announced that it has submitted its first "New Drug Application (NDA)" to the Drug Controller General of India for its oral pill "Desidustat" to treat anaemia in kidney patients.
Read More